Genmab (GMAB) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Genmab A/S is set to boost its share capital by issuing 10,355 new shares following the exercise of employee warrants, raising approximately DKK 11 million. The newly issued shares, which account for about 0.02% of Genmab’s share capital, will be listed on Nasdaq Copenhagen and offer standard shareholder rights. This move reflects Genmab’s commitment to expanding its financial resources as it continues to innovate in antibody therapeutics.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.
